PortfoliosLab logoPortfoliosLab logo
OKYO vs. CW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OKYO vs. CW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in OKYO Pharma Ltd ADR (OKYO) and Curtiss-Wright Corporation (CW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OKYO achieves a -18.36% return, which is significantly lower than CW's 37.01% return.


OKYO

1D
0.60%
1M
11.18%
6M
-38.77%
YTD
-18.36%
1Y
-39.86%
3Y*
16.64%
5Y*
10Y*

CW

1D
-0.65%
1M
-0.39%
6M
24.82%
YTD
37.01%
1Y
59.73%
3Y*
59.55%
5Y*
44.52%
10Y*
24.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OKYO vs. CW - Yearly Performance Comparison


2026 (YTD)2025202420232022
OKYO
OKYO Pharma Ltd ADR
-18.36%80.02%-35.03%-7.33%-57.56%
CW
Curtiss-Wright Corporation
37.01%55.66%59.73%33.98%21.87%

Correlation

The correlation between OKYO and CW is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since May 17, 2022

0.11

The correlation between OKYO and CW shifts across timeframes, from 0.11 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

OKYO:

$64.84M

CW:

$27.88B

EPS

OKYO:

-$0.20

CW:

$13.69

Total Revenue (TTM)

OKYO:

$0.00

CW:

$3.61B

Gross Profit (TTM)

OKYO:

-$6.82K

CW:

$1.34B

EBITDA (TTM)

OKYO:

-$9.59M

CW:

$745.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OKYO vs. CW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OKYO
OKYO Risk / Return Rank: 2222
Overall Rank
OKYO Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
OKYO Sortino Ratio Rank: 2424
Sortino Ratio Rank
OKYO Omega Ratio Rank: 2525
Omega Ratio Rank
OKYO Calmar Ratio Rank: 1515
Calmar Ratio Rank
OKYO Martin Ratio Rank: 2323
Martin Ratio Rank

CW
CW Risk / Return Rank: 8989
Overall Rank
CW Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CW Sortino Ratio Rank: 8585
Sortino Ratio Rank
CW Omega Ratio Rank: 8484
Omega Ratio Rank
CW Calmar Ratio Rank: 9393
Calmar Ratio Rank
CW Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OKYO vs. CW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for OKYO Pharma Ltd ADR (OKYO) and Curtiss-Wright Corporation (CW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OKYOCWDifference
Sharpe ratioReturn per unit of total volatility

-2.30

Sortino ratioReturn per unit of downside risk

-2.76

Omega ratioGain probability vs. loss probability

0.95

1.30

-0.35

Calmar ratioReturn relative to maximum drawdown

-0.75

4.60

-5.35

Martin ratioReturn relative to average drawdown

-1.03

13.21

-14.24

OKYO vs. CW - Sharpe Ratio Comparison

The current OKYO Sharpe Ratio is -0.52, which is lower than the CW Sharpe Ratio of 1.78. The chart below compares the historical Sharpe Ratios of OKYO and CW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OKYO vs. CW - Drawdown Comparison

The maximum OKYO drawdown since its inception was -79.15%, which is greater than CW's maximum drawdown of -59.19%. Use the drawdown chart below to compare losses from any high point for OKYO and CW.


Loading charts...

Drawdown Indicators


OKYOCWDifference

Max Drawdown

Largest peak-to-trough decline

-79.15%

-59.19%

-19.96%

Max Drawdown (1Y)

Largest decline over 1 year

-54.43%

-12.97%

-41.46%

Max Drawdown (3Y)

Largest decline over 3 years

-69.14%

-27.21%

-41.93%

Max Drawdown (5Y)

Largest decline over 5 years

-27.21%

Max Drawdown (10Y)

Largest decline over 10 years

-48.73%

Current Drawdown

Current decline from peak

-62.44%

-4.79%

-57.65%

Average Drawdown

Average peak-to-trough decline

-60.90%

-13.87%

-47.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.79%

4.50%

+35.29%

Volatility

OKYO vs. CW - Volatility Comparison

OKYO Pharma Ltd ADR (OKYO) has a higher volatility of 14.08% compared to Curtiss-Wright Corporation (CW) at 9.68%. This indicates that OKYO's price experiences larger fluctuations and is considered to be riskier than CW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OKYOCWDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.08%

9.68%

+4.40%

Volatility (6M)

Calculated over the trailing 6-month period

51.83%

25.84%

+25.99%

Volatility (1Y)

Calculated over the trailing 1-year period

79.17%

33.47%

+45.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

104.02%

27.92%

+76.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

104.02%

30.30%

+73.72%

Dividends

OKYO vs. CW - Dividend Comparison

OKYO has not paid dividends to shareholders, while CW's dividend yield for the trailing twelve months is around 0.13%.


PositionTTM20252024202320222021202020192018201720162015
CW
Curtiss-Wright Corporation
0.13%0.17%0.23%0.35%0.45%0.51%0.58%0.47%0.59%0.46%0.53%0.76%
OKYO
OKYO Pharma Ltd ADR
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

OKYO vs. CW - Financials Comparison

This section allows you to compare key financial metrics between OKYO Pharma Ltd ADR and Curtiss-Wright Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B202220232024202520260
913.69M
(OKYO) Total Revenue
(CW) Total Revenue
Values in USD except per share items

Frequently Asked Questions


OKYO and CW have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OKYO has higher volatility (14.08%) compared to CW (9.68%). In terms of maximum drawdown, OKYO dropped -79.15% vs CW's -59.19%.

CW currently has the higher Sharpe Ratio (1.78 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OKYO and CW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer